National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Cervical/Uterine Cancers Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Nadeem R. Abu-Rustum, MD

None

None

None

None

7/1/2009

Sachin M. Apte, MD, MS

None

None

None

None

11/18/2009

Robert E. Bristow, MD

John`s Hopkins University

Genzyme Corporation;
Oncotech

None

None

11/17/2009

Susana M. Campos, MD, MPH, MS

None

None

None

None

1/2/2009

John Chan, MD

       

Pending

Kathleen R. Cho, MD

None

None

None

None

9/28/2009

Larry Copeland, MD

Eli Lilly and Company;
Genentech, Inc.;
Gynecologic Oncology Group

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

10/2/2009

Marta Ann Crispens, MD

None

None

None

None

10/13/2009

Nefertiti DuPont, MD, MPH

None

None

None

None

7/1/2009

Patricia J Eifel, MD

None

None

None

None

11/17/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Benjamin E. Greer, MD

None

None

None

None

11/16/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

7/21/2009

Warner K Huh, MD

GlaxoSmithKline;
Merck & Co., Inc.;
MGI PHARMA, INC.;
Takeda Pharmaceuticals North America, Inc.

GlaxoSmithKline;
Intuitive Surgical, Inc.;
Merck & Co., Inc.

None

None

11/16/2009

Daniel S. Kapp, MD, PhD

None

None

None

None

11/16/2009

Wui-Jin Koh, MD

Gynecologic Oncology Group

None

None

None

7/1/2009

John R. Lurain, MD

None

None

None

None

10/1/2009

Lainie Martin, MD

None

None

None

None

11/16/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Nicole McMillian, MS

None

None

None

None

7/21/2009

Mark A. Morgan, MD, FACOG, FACS

None

None

None

None

11/16/2009

Robert J. Morgan, MD, FACP

NIH-CTEP

None

Abbott Laboratories

None

7/1/2009

Steven W. Remmenga, MD

None

None

None

None

9/28/2009

R. Kevin Reynolds, MD

None

None

None

None

9/28/2009

Angeles A. Secord, MD

Bristol-Myers Squibb Company

Abraxis Oncology;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
sanofi-aventis U.S.

None

None

9/28/2009

William Small, MD

Genentech, Inc.

DOR BioPharma, Inc.

None

None

7/1/2009

Nelson Teng, MD, PhD

GOG

None

None

None

11/16/2009

 

NCCN Website Supporters